FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2118216199> ?p ?o ?g. }

• W2118216199 endingPage "1600" @default.
• W2118216199 startingPage "1593" @default.
• W2118216199 abstract "Continuous-flow left ventricular assist devices (LVADs) such as the HeartMate II have become the therapy of choice in patients with end-stage heart failure. The aim of this study is to report the outcomes in patients receiving the HeartMate II LVAD at a single center and review the lessons learned from this experience.From June 2005 to June 2010, 130 consecutive patients received the HeartMate II LVAD. Of these, 102 were bridge-to-transplant (BTT), 17 destination therapy, and 11 exchanges for failed HeartMate XVE. This study focuses on the 102 BTT patients. The HeartMate II was approved by the US Food and Drug Administration (FDA) as BTT in April 2008 and 64 patients received this device as BTT since that date. We review our experience with the device as BTT and report on patient survival and adverse events as well as the impact of FDA approval on outcomes.Overall, mean age was 52.6 ± 12.8 years; 26 (25.5%) were female. Disease etiology was ischemic in 58, nonischemic in 36, and other in 8. Overall, 30-day, 6-month, and 1-year survival for the BTT patients was 95.1%, 83.5%, and 78.8%, respectively. The 6-month survival in 38 patients in the clinical trial (pre-FDA) was 88.8% and was not statistically significant compared with the 76.2% 6-month survival in the 64 patients in the post-FDA approval period (p value = 0.1). Major adverse events among the 102 BTT patients included right ventricular failure in 5 (4.9%), LVAD driveline infections in 25 (24.5%), neurologic events in 10 (9.8%), and gastrointestinal bleeding in 18 (17.6%) patients. In addition, 1 patient (0.98%) had pump thrombus requiring device replacement.Despite significant morbidity, use of the HeartMate II LVAD as BTT provides excellent hemodynamic support and is associated with excellent survival and low mortality. In addition, there needs to be improvement and focused strategies in the areas of gastrointestinal bleeding, driveline infections, and adverse neurologic events for these devices to be able to provide a real long-term alternative to heart transplantation." @default.
• W2118216199 created "2016-06-24" @default.
• W2118216199 creator A5007806159 @default.
• W2118216199 creator A5009333228 @default.
• W2118216199 creator A5010251316 @default.
• W2118216199 creator A5026807680 @default.
• W2118216199 creator A5044941803 @default.
• W2118216199 creator A5048636771 @default.
• W2118216199 creator A5080446143 @default.
• W2118216199 creator A5085683956 @default.
• W2118216199 date "2011-11-01" @default.
• W2118216199 modified "2023-09-25" @default.
• W2118216199 title "Lessons Learned From Experience With Over 100 Consecutive HeartMate II Left Ventricular Assist Devices" @default.
• W2118216199 cites W1965515198 @default.
• W2118216199 cites W1997669401 @default.
• W2118216199 cites W2010798210 @default.
• W2118216199 cites W2013993096 @default.
• W2118216199 cites W2019534498 @default.
• W2118216199 cites W2023233861 @default.
• W2118216199 cites W2025279071 @default.
• W2118216199 cites W2036716682 @default.
• W2118216199 cites W2041092771 @default.
• W2118216199 cites W2043431972 @default.
• W2118216199 cites W2050033436 @default.
• W2118216199 cites W2059970701 @default.
• W2118216199 cites W2075169049 @default.
• W2118216199 cites W2077702940 @default.
• W2118216199 cites W2079613552 @default.
• W2118216199 cites W2081024528 @default.
• W2118216199 cites W2092322834 @default.
• W2118216199 cites W2113513543 @default.
• W2118216199 cites W2140171895 @default.
• W2118216199 cites W2151998588 @default.
• W2118216199 cites W2165719156 @default.
• W2118216199 cites W2168408687 @default.
• W2118216199 cites W2169138421 @default.
• W2118216199 doi "https://doi.org/10.1016/j.athoracsur.2011.06.081" @default.
• W2118216199 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22051256" @default.
• W2118216199 hasPublicationYear "2011" @default.
• W2118216199 type Work @default.
• W2118216199 sameAs 2118216199 @default.
• W2118216199 citedByCount "84" @default.
• W2118216199 countsByYear W21182161992012 @default.
• W2118216199 countsByYear W21182161992013 @default.
• W2118216199 countsByYear W21182161992014 @default.
• W2118216199 countsByYear W21182161992015 @default.
• W2118216199 countsByYear W21182161992016 @default.
• W2118216199 countsByYear W21182161992017 @default.
• W2118216199 countsByYear W21182161992018 @default.
• W2118216199 countsByYear W21182161992019 @default.
• W2118216199 countsByYear W21182161992020 @default.
• W2118216199 countsByYear W21182161992021 @default.
• W2118216199 countsByYear W21182161992022 @default.
• W2118216199 countsByYear W21182161992023 @default.
• W2118216199 crossrefType "journal-article" @default.
• W2118216199 hasAuthorship W2118216199A5007806159 @default.
• W2118216199 hasAuthorship W2118216199A5009333228 @default.
• W2118216199 hasAuthorship W2118216199A5010251316 @default.
• W2118216199 hasAuthorship W2118216199A5026807680 @default.
• W2118216199 hasAuthorship W2118216199A5044941803 @default.
• W2118216199 hasAuthorship W2118216199A5048636771 @default.
• W2118216199 hasAuthorship W2118216199A5080446143 @default.
• W2118216199 hasAuthorship W2118216199A5085683956 @default.
• W2118216199 hasConcept C126322002 @default.
• W2118216199 hasConcept C137627325 @default.
• W2118216199 hasConcept C141071460 @default.
• W2118216199 hasConcept C164705383 @default.
• W2118216199 hasConcept C197934379 @default.
• W2118216199 hasConcept C2778198053 @default.
• W2118216199 hasConcept C2778620186 @default.
• W2118216199 hasConcept C2778774980 @default.
• W2118216199 hasConcept C2779326848 @default.
• W2118216199 hasConcept C3018890749 @default.
• W2118216199 hasConcept C535046627 @default.
• W2118216199 hasConcept C545542383 @default.
• W2118216199 hasConcept C71924100 @default.
• W2118216199 hasConceptScore W2118216199C126322002 @default.
• W2118216199 hasConceptScore W2118216199C137627325 @default.
• W2118216199 hasConceptScore W2118216199C141071460 @default.
• W2118216199 hasConceptScore W2118216199C164705383 @default.
• W2118216199 hasConceptScore W2118216199C197934379 @default.
• W2118216199 hasConceptScore W2118216199C2778198053 @default.
• W2118216199 hasConceptScore W2118216199C2778620186 @default.
• W2118216199 hasConceptScore W2118216199C2778774980 @default.
• W2118216199 hasConceptScore W2118216199C2779326848 @default.
• W2118216199 hasConceptScore W2118216199C3018890749 @default.
• W2118216199 hasConceptScore W2118216199C535046627 @default.
• W2118216199 hasConceptScore W2118216199C545542383 @default.
• W2118216199 hasConceptScore W2118216199C71924100 @default.
• W2118216199 hasIssue "5" @default.
• W2118216199 hasLocation W21182161991 @default.
• W2118216199 hasLocation W21182161992 @default.
• W2118216199 hasOpenAccess W2118216199 @default.
• W2118216199 hasPrimaryLocation W21182161991 @default.
• W2118216199 hasRelatedWork W2036455093 @default.
• W2118216199 hasRelatedWork W2098351541 @default.
• W2118216199 hasRelatedWork W2118216199 @default.
• W2118216199 hasRelatedWork W2143015101 @default.

• next